betrixaban

Betrixaban: New Oral Blood Thinner Cleared by FDA

The U.S. Food and Drug Administration has granted Portola Pharmaceuticals permission to market …

Read the full story

Current News

COVET Trial Opens for Enrollment

The COVET (Comparison of Oral anticoagulants for extended VEnous Thromboembolism) clinical trial is now open for enrollment. This study is…

December e-Newsletter | ‘Tis the Season

This holiday season, the National Blood Clot Alliance (NBCA) wishes you and the people you care about happiness and good health.…